Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: New_Riluzole_study_published

Posted by SLS on February 22, 2005, at 7:38:35

In reply to New_Riluzole_study_published, posted by EERRIICC on February 21, 2005, at 19:34:22

Hi.

I suffer from bipolar depression. I hope riluzole (Rilutek) helps others more than it helped me. Although I didn't experience anything positive, I didn't experience anything untoward either.

Riluzole is prohibitively expensive, and the drug company wants to keep it that way. The company even denied the NIMH request to donate a supply of the drug for their investigation.

Currently the only FDA approved indication for riluzole is for the treatment of ALS (amyotrophic lateral sclerosis).


- Scott.

> 1: Biol Psychiatry. 2005 Feb 15;57(4):430-2. Related Articles, Links
>
>
> An open-label trial of the glutamate-modulating agent riluzole in combination with lithium for the treatment of bipolar depression.
>
> Zarate CA Jr, Quiroz JA, Singh JB, Denicoff KD, De Jesus G, Luckenbaugh DA, Charney DS, Manji HK.
>
> Laboratory of Molecular Pathophysiology, National Institute of Mental Health, Bethesda, Maryland; Mood and Anxiety Disorders Program, National Institute of Mental Health, Bethesda, Maryland.
>
> BACKGROUND: Preclinical and clinical evidence indicate that the glutamatergic system might play a role in the pathophysiology of mood disorders. This study was conducted to determine the efficacy and safety of riluzole, a glutamate-modulating agent, in bipolar depression. METHODS: This was an 8-week add-on study of riluzole in combination with lithium in acutely depressed bipolar patients aged 18 years and older. After open treatment with lithium for a minimum period of 4 weeks, subjects who continued to have a Montgomery-Asberg Depression Rating Scale (MADRS) score of >/=20 received riluzole (50-200 mg/day) for 8 weeks. RESULTS: Fourteen bipolar depressed patients entered the study. The linear mixed models for total MADRS score showed a significant treatment effect. No switch into hypomania or mania was observed. Overall, riluzole was well tolerated. CONCLUSIONS: Although preliminary, these results suggest that riluzole might indeed have antidepressant efficacy in subjects with bipolar depression.
>
> PMID: 15705360 [PubMed - in process]
>

 

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:SLS thread:461518
URL: http://www.dr-bob.org/babble/20050222/msgs/461686.html